Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
7.84
-0.15 (-1.88%)
Mar 9, 2026, 1:31 PM EDT - Market open
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $481.69 million as of March 9, 2026. Its market cap has increased by 279.46% in one year.
Market Cap
481.69M
Enterprise Value
421.68M
1-Year Change
279.46%
Ranking
Category
Stock Price
$7.84
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $481.69M, an increase of 681.73%. That is a compound annual growth rate of 50.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 481.69M | 26.36% |
| Dec 31, 2025 | 381.21M | 241.41% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 507.03M |
| Zevra Therapeutics | 505.55M |
| Lexeo Therapeutics | 499.96M |
| Immix Biopharma | 489.54M |
| Rocket Pharmaceuticals | 478.79M |
| Lyell Immunopharma | 477.14M |
| Atea Pharmaceuticals | 469.27M |
| Vanda Pharmaceuticals | 466.36M |